SGE Smoking Cessation Innovation.
Completed
- Conditions
- SmokingSmoking cessationVareniclinePractice nurseIntensive counsellingHealth care innovation
- Registration Number
- NL-OMON23449
- Lead Sponsor
- D. KotzResearch Institute CAPHRI, Department of General Practice, Maastricht University P. Debyeplein 1, 6229 HA, Maastricht P.O. Box 616, 6200 MD Maastricht, The Netherlands T 043-3882893F 043-3619344
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 272
Inclusion Criteria
We aim to recruit those adult smokers into the trial who normally consult with their general practitioner in primary care.
Exclusion Criteria
Participants are excluded from the study when they:
1. Do not smoke daily;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prolonged smoking abstinence from week 9 to week 26. Smoking abstinence will be validated by measuring exhaled carbon monoxide (CO) in all self-reported non-smokers.
- Secondary Outcome Measures
Name Time Method The secondary outcome parameters are:<br /><br>1. Cost-effectiveness of the two smoking cessation treatments, expressed as the intervention costs per quitter;<br /><br>2. Compliance with varenicline in both treatment groups.